INTRODUCTION
Infl ammation represents a highly coordinated sequence of events in which tissues respond to physical trauma, noxious chemicals, or pathogens. [1] Infl ammatory processes are involved in immune surveillance and optimal repair and regeneration, following injury. [2] However, sustained excessive or irrelevant inflammation is the cause of many diseases including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Inflammation is a major component of the damage caused by autoimmune diseases and is a key contributor to pathologies such as cancer, diabetes, and cardiovascular disease. [3] Use of herbal extracts for treatment of infl ammatory diseases is well documented in Ayurveda, the medicinal system of ancient India. [4] Ajmodadi churna (AJM) is a polyherbal Ayurvedic medicine traditionally used as a carminative, antispasmodic, wormifuge, or in sciatica. [5, 6] The antiinfl ammatory activity of its six ingredients, Trachyspermum ammi, [7] Cedrus deodara, [8] Piper longum, [9] Terminalia chebula, [10] Argyreia nervosa, [11] and Zingiber offi cinale, [12] has previously been studied on an individual basis. In addition to their antinfl ammatory properties, all the ingredients have been shown to possess additional biological activity. Trachyspermum ammi has also been reported to possess analgesic, antibacterial, antifilarial, antifungal, antiviral, and gastroprotective activities. [13] Embelia ribes exhibits a wide range of activity: Hepatoprotective, analgesic, amylase and trypsin inhibitory, antibacterial, antioxidant, antidiabetic, anticonvulsant, adaptogenic, antifertility, anticancer, antihyperlipidemic, and antifungal. [14] In Cedrus deodara, antioxidant [15] and anticancer [16] activity is reportedto be significant. Plumbago zeylanica reported to possess anticancer, [17] [18] [19] antibacterial, [20] antiinflammatory, [21] antileishmanial, [22] antifungal, [23] hyperglycemic, [24] and hypolipidemic [25] activities. Piper longum exhibits antioxidant, antiallergic, antidiabetic, anticancer, immunomodulatory, antiviral, antiulcer, antidepressant, and hepatoprotective activities. [26] Anethum graveolens has been reported to possess anticancer, antidiabetic, antioxidant, antisecretory, antispasmodic, insecticidal, and diuretic properties. [27] Piper nigrum is said to possess antioxidant, antiplatelet, antihypertensive, antitumor, antithyroid, antiasthmatic, and hepatoprotective activities. [28] Terminalia chebula exhibits antiviral, antibacterial, antioxidant, antibacterial, radioprotective, wound healing, and immunomodulatory activities. [10] Argyreia nervosa is used in wound healing, rheumatic disorders, leucohorrhoea, ulcer, cancer, and syphilis; also as a diuretic and to prevent contraception. [29] Zingiber officinale exhibits immunomodulatory, antitumorigenic, antiinfl ammatory, antiapoptotic, antihyperglycemic, antilipidemic, and antiemetic actions. [30] In addition, the combination, Piper longum, Piper nigrum, and Zingiber offi cinale, known in Ayurveda as Trikatu, is a signifi cant bioenhancer. [31] However, no scientifi c data on antiinfl ammatory activity of the overall formulation are available. The present study evaluated the potential use of aqueous extracts of AJM to treat acute infl ammatory toxicity.
MATERIALS AND METHODS

Plant materials and chemicals
All the 12 ingredients of AJM were procured from Jogappa Shanbhag Ayurvedic Pharmacy, Udupi, Karnataka, India, and were authenticated by Dr. Gopal Krishna Bhat, Department of Botany, Poorna Prajna College, Udupi, Karnataka. Voucher specimens of the same were deposited in the museum of the Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal.
[ Table 1 ]. All chemicals used in the experiment were of analytical grade.
Ajmodadi churna preparation
The churna was prepared according to the method given in Ayurvedic Formulary of India. [5] All the ingredients were powdered separately, passed through a 80 # sieve, and then mixed together in specifi ed proportions to yield a uniformly blended churna.
Aqueous extract preparation
Powdered AJM (100 g) was macerated with chloroformwater (1:99 v/v) for 7 days with intermittent shaking. The resulting aqueous extract was concentrated under reduced pressure at 40°C and lyophilized (−40°C) to obtain a solid brown residue (yield: 24.6 g), which was stored in a dessicator until use.
Experimental animals
Female Wistar rats weighing 130-150 g were used. All animals were housed in polypropylene cages in a temperature-controlled room at 24 ± 1°C. They were fed with pelleted rat feed manufactured by Hindustan Lever Ltd, Mumbai, and enjoyed free access to water throughout the experiment. Rats were acclimatized at least 1 week before starting the experiment. For Carrageenan induced hind paw edema and air pouch infl ammation models, rats were divided into four groups with six rats in each group. Group I was control group and received 0.25% CMC. Diclofenac sodium served as the standard drug and was given to the group II. The churna extract (200 mg/kg and 400 mg/kg) were administered to the group III and group IV respectively. 
Acute toxicity study
Graded doses (1200-4000 mg/kg) of AJM were tested for acute toxicity, according to OECD guideline no. 420. After drug administration, the animals were evaluated every 10 min for 4 hours and then at 24, 48, and 72 hours for changes in visual placing, stereotypy, passivity, grooming, restlessness, irritability, and other behavioral activities. Doses for the reported studies were chosen to be 1/10 th and 1/20 th of the maximum tolerated dose.
Carrageenan-induced hind paw edema in rats
The acute antiinflammatory effect was evaluated by carrageenan-induced hind paw edema. [32] The edema was induced by injection of 1% suspension of carrageenan in 0.9% sterile saline solution into the rat's right plantar region. The churna extract (200 and 400 mg/kg), diclofenac sodium (10 mg/kg body weight), or vehicle was administrated orally 1 hour before injection of carrageenan. Rats' paw volumes were measured by digital Plethysmometer at hours 0, 3, and 5, after injection. [33] 
Carrageenan-induced air pouch infl ammation in rats
On day 1, the rat's dorsal sides were shaved (1 cm 2 ) under ether anesthesia and disinfected, then air cavities were produced by subcutaneous injection of 20 ml of sterile air with a 28-gauge needle. An additional 20 ml of air was injected on day 3 and experimental animals were grouped. On day 5 after the initial air injection, 1 ml of 1% w/v carrageenan dissolved in saline was injected directly into the pouch to produce an inflammatory response for all groups except the negative controls which received 1 ml of saline. Six hours after carrageenan injection, the animals were sacrifi ced under ether anesthesia, and 5 ml of ice-cold saline was injected into the pouch. The pouch was gently massaged for a minute, cut open carefully, and any exudate collected. Total leukocyte count of lavage fl uid was measured using an Erma Veterinary cell counter, from Japan). The percentage myeloperoxidase (MPO) activity was determined by adding 50 l sample/standard/50 mM phosphate buffer (pH 6) (blank) into the respective well. Then, 250 l of O-dianisidine hydrochloride 0.167 mg/ml in 50 mM phosphate buffer (pH 6) containing 0.0005% hydrogen peroxide) was added. The plate was read after 5 and 15 mins at 490 nm. After 15 mins incubation, 50 l 4 M H 2 SO 4 was added to stop the reaction and readings were taken. Percentage MPO activity compared to control was calculated and presented as mean % MPO activity±S.E.M. [34, 35] 
Statistical analysis
Statistical significance (P) was calculated by one-way ANOVA between AJM-treated and control groups, followed by Dunnett's post hoc test of signifi cance. All data were expressed as mean±S.E.M.
RESULTS
AJM did not produce any death till 72 hour at 4000 mg/kg, p.o. and no apparent adverse symptoms were observed. Figure 1 shows the inhibitory effect of aqueous extract of AJM on carrageenan-induced paw edema in rats. Maximum phlogistic response of carrageenan was observed at 1-3 hours after the injection in the control animals. 
DISCUSSION
Aqueous extracts of AJM were investigated for their antiinflammatory activity in two study models. AJM signifi cantly reduced paw edema, during the second phase of edema development, between 1 and 4 hours, suggesting an inhibitory response in prostaglandin-mediated Results were analyzed by one-way ANOVA followed by post hoc Dunnett's test. *P<0.05, **P<0.01, and ***P<0.0001, compared to controls infl ammatory pathways. [36, 37] In the carrageenan-induced air pouch model, AJM inhibited cellular infiltration (neutrophils and granulocytes) into the air pouch fl uid. Also, MPO from the neutrophils' azurophilic granules, is responsible for invoking tissue damage. [38] Our results indicate that AJM has considerable therapeutic potential as an inhibitor of MPO-mediated tissue injury. This study suggests that AJM is a promising, plant-based, antiinfl ammatory agent, for treatment of infl ammatory disorders and conditions. Its antiinfl ammatory activity on humans under clinical conditions should now be evaluated.
